The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Role of the medial prefrontal cortex in 5‐HT1A receptor‐induced inhibition of 5‐HT neuronal activity in the rat
Open accessAbstract
We examined the involvement of the frontal cortex in the 5‐HT 1A receptor‐induced inhibition of 5‐HT neurones in the dorsal raphe nucleus (DRN) of the anaesthetized rat using single‐unit recordings complemented by Fos‐immunocytochemistry. Both transection of the frontal cortex as well as ablation of the medial region of the prefrontal cortex (mPFC) significantly attenuated the inhibition of 5‐HT neurones induced by systemic administration of the 5‐HT 1A receptor agonist, 8‐OH‐DPAT (0.5–16 μg kg−1, i.v.). In comparison, the response to 8‐OH‐DPAT was not altered by ablation of the parietal cortex. The inhibitory effect of 8‐OH‐DPAT was reversed by the 5‐HT 1A receptor antagonist, WAY 100635 (0.1 mg kg−1, i.v.) in all neurones tested. In contrast, cortical transection did not alter the sensitivity of 5‐HT neurones to iontophoretic application of 8‐OH‐DPAT into the DRN. Similarly, cortical transection did not alter the sensitivity of 5‐HT neurones to systemic administration of the selective 5‐HT reuptake inhibitor, paroxetine (0.1–0.8 mg kg−1, i.v.). 8‐OH‐DPAT evoked excitation of mPFC neurones at doses (0.5–32 μg kg−1, i.v.) in the range of those which inhibited 5‐HT cell firing. At higher doses (32–512 μg kg−1, i.v.) 8‐OH‐DPAT inhibited mPFC neurones. 8‐OH‐DPAT (0.1 mg kg−1, s.c.) also induced Fos expression in the mPFC. The neuronal excitation and inhibition, as well as the Fos expression, were antagonized by WAY 100635. These data add further support to the view that the inhibitory effect of 5‐HT 1A receptor agonists on the firing activity of DRN 5‐HT neurones involves, in part, activation of a 5‐HT 1A receptor‐mediated postsynaptic feedback loop centred on the mPFC. British Journal of Pharmacology (1999) 126, 1741–1750; doi:10.1038/sj.bjp.0702510
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnsten, A. F. T., & Goldman-Rakic, P. S. (1984) · Brain Research · doi:10.1016/0006-8993(84)90351-2 · Cited by 333
The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain
Burnet, P. W. J., Eastwood, S. L., Lacey, K., & Harrison, P. J. (1995) · Brain Research · doi:10.1016/0006-8993(95)00104-x · Cited by 283
Cited by
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
Self-citationStress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects
Mahar, I., Bambico, F. R., Mechawar, N., & Nobrega, J. N. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.009 · Cited by 694
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats
Carta, M., Carlsson, T., Kirik, D., & Bjorklund, A. (2007) · Brain · doi:10.1093/brain/awm082 · Cited by 636
Is there a role for 5-HT1A agonists in the treatment of depression?
Blier, P., & Ward, N. M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01643-8 · Cited by 529
Celada, P., Puig, M. V., Casanovas, J. M., Guillazo, G., & Artigas, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09917.2001 · Cited by 497
Serotonin modulation of cortical neurons and networks
Celada, P., Puig, M. V., & Artigas, F. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00025 · Cited by 462
“…(increase in firing activity at lower doses followed by decrease at higher doses) or affecting different neuronal populations in a distinct manner (most neurons excited by 5-HT1A agonists) (Borsini et al., 1995; Hajos et al., 1999; Diaz-Mataix et al., 2006; LladóPelfort et al., 2010, 2012a,b).”
BackgroundSerotonin4 (5-HT4) Receptor Agonists Are Putative Antidepressants with a Rapid Onset of Action
Lucas, G., Rymar, V. V., Du, J., Mnie-Filali, O., Bisgaard, C., Manta, S., Lambas-Senas, L., Wiborg, O., Haddjeri, N., Piñeyro, G., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.041 · Cited by 359
Bambico, F. R., Katz, N., Debonnel, G., & Gobbi, G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1636-07.2007 · Cited by 325
“The transection procedure did not significantly modify the basal discharge rate of DR 5-HT neurons as was also observed by Hajos et al. (1999).”
BackgroundResultInfluentialWinstanley, C. A., Theobald, D. E. H., Dalley, J. W., Glennon, J. C., & Robbins, T. W. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1884-9 · Cited by 324
Celada, P., Bortolozzi, A., & Artigas, F. (2013) · CNS Drugs · doi:10.1007/s40263-013-0071-0 · Cited by 323
Serotonin and psychostimulant addiction: Focus on 5-HT1A-receptors
Müller, C. P., Carey, R. J., Huston, J. P., & De Souza Silva, M. A. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.01.001 · Cited by 302
Steketee, J. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00233-3 · Cited by 293
Stahl, S. M., Sommer, B., & Allers, K. A. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.02032.x · Cited by 293
Díaz-Mataix, L., Scorza, M. C., Bortolozzi, A., Toth, M., Celada, P., & Artigas, F. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2999-05.2005 · Cited by 285
5-HT1A Receptors, Gene Repression, and Depression: Guilt by Association
Albert, P. R., & Lemonde, S. (2004) · The Neuroscientist · doi:10.1177/1073858404267382 · Cited by 275
Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease
Holmes, A. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.03.006 · Cited by 264
Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei
Adell, A., Celada, P., Abellán, M. T., & Artigas, F. (2002) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00182-0 · Cited by 254
Winstanley, C. A., Chudasama, Y., Dalley, J. W., Theobald, D. E. H., Glennon, J. C., & Robbins, T. W. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1398-x · Cited by 234
“…and neuroanatomical data indicate that both 5-HT1A and 5-HT2A receptors are involved in regulating a feedback projection from the mPFC to the DRN (Hajos et al. 1999; Casanovas et al. 1999) through a glutamate-dependent mechanism (Scruggs et al. 2000; Celada et al. 2001; Martin-Ruiz et al. 2001).”
BackgroundRichardson-Jones, J. W., Craige, C. P., Nguyen, T. H., Kung, H. F., Gardier, A. M., Dranovsky, A., David, D. J., Guiard, B. P., Beck, S. G., Hen, R., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5836-10.2011 · Cited by 192
Llado-Pelfort, L., Santana, N., Ghisi, V., Artigas, F., & Celada, P. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr220 · Cited by 156
Bland, S. T., Hargrave, D., Pepin, J. L., Amat, J., Watkins, L. R., & Maier, S. F. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300206 · Cited by 155
Serotonin–dopamine interaction in the induction and maintenance of l-DOPA-induced dyskinesias
CARTA, M., CARLSSON, T., MUNOZ, A., KIRIK, D., & BJORKLUND, A. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00922-9 · Cited by 131
De Kock, C. P. J., Cornelisse, L. N., Burnashev, N., Lodder, J. C., Timmerman, A. J., Couey, J. J., Mansvelder, H. D., & Brussaard, A. B. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.115311 · Cited by 55
Calcagno, E., Carli, M., & Invernizzi, R. W. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03600.x · Cited by 54
Chipman, P., Jorm, A. F., Tan, X.-Y., & Easteal, S. (2010) · Psychiatric Genetics · doi:10.1097/ypg.0b013e3283351140 · Cited by 24
“firing of serotonergic neurons in the dorsal raphe nucleus through a negative feed-back loop (Hajós et al., 1999; Celada et al., 2001).”
BackgroundPravikova, P. D., Moskaliuk, V. S., Bazovkina, D. V., Kozhemyakina, R. V., & Naumenko, V. S. (2024) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093024060218 · Cited by 1
Metadata
- Authors
- Hajós, M., Hajós‐Korcsok, É., & Sharp, T.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1999-04
- Volume
- 126
- Issue
- 8
- Pages
- 1741-1750
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2020016243
- Cited by
- 210
- References
- 2
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.